PRQR ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/13/2026
EPSå®çžŸïŒUSDïŒ-0.09
売äžé«å®çžŸïŒUSDïŒ10.10M
ProQR Therapeutics NVã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® ProQR Therapeutics NV ã®æ±ºç®å ±åæžã次å ProQR Therapeutics NV ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãProQR Therapeutics NV ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠ProQR Therapeutics NV ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
PRQR 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
PRQR FY2025 決ç®
EPS (å幎åææ¯)-0.47-40.88%
売äžé« (å幎åææ¯)18.82M-11.29%
ProQR Therapeutics NVïŒPRQRïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.09/-0.13 | 10.10M/5.24M | 30.56% | 92.62% |
| 5/12/2026 | 03/2026 | -0.15/-0.14 | 2.39M/6.01M | -7.14% | -60.28% |
| 3/12/2026 | 12/2025 | -0.10/-0.12 | 4.10M/4.36M | 14.36% | -6.00% |
| 11/6/2025 | 09/2025 | -0.12/-0.12 | 2.52M/4.99M | -4.02% | -49.45% |
| 8/7/2025 | 06/2025 | -0.14/-0.09 | 3.41M/5.14M | -44.07% | -33.69% |
| 5/8/2025 | 03/2025 | -0.10/-0.08 | 4.22M/3.84M | -31.95% | 9.96% |
| 3/13/2025 | 12/2024 | -0.10/-0.08 | 4.09M/5.08M | -22.18% | -19.35% |
| 11/7/2024 | 09/2024 | -0.11/-0.09 | 3.68M/9.65M | -20.26% | -61.80% |